Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Chem-Med Company CHEM-MED COMPANY Income Statements 20XU20XW (in thousands) Pro Forma Income Statements 20XU 20XV 20XW 20XX 20XY 20XZ Net sales (all credit)............................ $ 777

Chem-Med Company

CHEM-MED COMPANY
Income Statements
20XU20XW (in thousands) Pro Forma Income Statements
20XU 20XV 20XW 20XX 20XY 20XZ
Net sales (all credit)............................ $ 777 $3,051 $3,814 $5,340 $7,475 $10,366
Cost of goods sold.............................. 257 995 1,040 1,716 2,154 2,954
Gross profit........................................ 520 2,056 2,774 3,624 5,321 7,412
Selling, etc., expenses......................... 610 705 964 1,520 2,120 2,645
Other income (expenses)*................... 0 0 0 500 0 0
Operating profit................................... (90) 1,351 1,810 2,604 3,201 4,767
Interest expense.................................... 11 75 94 202 302 434
Income before tax................................ (101) 1,276 1,716 2,402 2,899 4,333
Income taxes........................................
(40% in 20XV; 33% thereafter)....... 0 510 566 793 957 1,430
Net income.......................................... ($ 101) $ 766 $1,150 $1,609 $1,942 $ 2,903
Dividends paid.................................... 0 0 0 0 0 0
Increase in retained earnings............. $ (101) $ 766 $1,150 $1,609 $1,942 $ 2,903
Average number of shares**............... 2,326 2,326 2,347 2,347 2,347 2,347
Earnings per share.............................. ($0.04) $0.33 $0.49 $0.69 $0.83 $1.24
*Other income (expenses) refers to extraordinary gains and losses. In 20XX, $500,000 is expected from Pharmacia Inc., in settlement of the lawsuit. **Shares are not publicly traded.
Table 1

CHEM-MED COMPANY
Balance Sheets (in thousands)
Pro Forma Balance Sheets as of Dec. 31, years ended:
20XU 20XV 20XW 20XX 20XY 20XZ
Assets
Cash and equivalent..................................... $ 124 $ 103 $ 167 $ 205 $ 422 $ 101
Accounts receivable..................................... 100 409 564 907 1,495 2,351
Inventories....................................................... 151 302 960 1,102 1,443 798
Other current.................................................. 28 59 29 41 57 11
Total current assets................................ 403 873 1,720 2,255 3,417 3,261
Property, plant, & equipment...................... 1,901 2,298 2,917 4,301 5,531 8,923
Less: Accumulated amortization......... 81 82 346 413 522 588
Property, plant, & equipment net.............. 1,820 2,216 2,571 3,888 5,009 8,335
Other capital assets...................................... 0 101 200 200 215 399
Total assets..................................................... $2,223 $3,190 $4,491 $6,343 $8,641 $11,995
Liabilities
Accounts payable......................................... $210 $ 405 $ 551 $771 $1,080 $ 1,512
Short-term debt............................................. 35 39 42 59 82 135
Total current liabilities............................. 245 444 593 830 1,162 1,647
Long-term debt.............................................. 17 19 21 27 50 17
Total liabilities........................................... 262 463 614 857 1,212 1,664
Equity
Common stock.............................................. 2,062 2,062 2,062 2,062 2,062 2,062
Retained earnings......................................... (101) 665 1,815 3,424 5,366 8,269
Total equity................................................ 1,961 2,727 3,877 5,486 7,428 10,331
Total liabilities and equity............................ $2,223 $3,190 $4,491 $6,343 $8,640 $11,995
Table 2

Biotechnology Industry StatisticsMedian Company in Biological Products
20XU 20XV 20XW
Current ratio.................................. 2.5 2.3 2.4
Quick ratio..................................... 1.2 1.1 1.3
Inventory turnover......................... 5.5 5.6 5.7
Total asset turnover........................ 1.15 1.16 1.18
Return on sales.............................. 4.00% 4.00% 5.00%
Return on assets.............................. 4.60% 4.64% 5.90%
Return on equity............................ 7.64% 8.44% 12.29%
Total debt to assets......................... 0.40 0.45 0.52
Selected Statistics, Pharmacia Company
20XU 20XV 20XW
Current ratio................................... 2.8 2.7 2.8
Quick ratio..................................... 1.5 1.3 1.6
Inventory turnover.......................... 5.6 5.7 5.8
Total asset turnover......................... 1.9 2 1.9
Return on sales.............................. 6.00% 6.50% 7.00%
Return on assets.............................. 11.40% 13.00% 13.30%
Return on equity............................ 19.04% 27.66% 29.56%
Total debt to assets........................ 0.40 0.53 0.55
Price-earnings ratio......................... 13.7 14 15
Average share price....................... $21.78 $24.92 $31.50
Table 3

  1. What is the companys rate of net income growth in 20XX, 20XY, and 20XZ? Is projected net income growing faster or slower than projected sales? After computing these values, take a hard look at the 20XX income statement data to see if you want to make any adjustments.
  2. How does ChemMeds current ratio for 20XW compare to Pharmacias? How does it compare to the industry average? Compute ChemMeds current ratio for 20XZ. Is there any problem with it?

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Pricing And Hedging Financial Derivatives A Guide For Practitioners

Authors: Leonardo Marroni, Irene Perdomo

1st Edition

1119953715, 978-1119953715

More Books

Students also viewed these Finance questions

Question

Describe a persuasive message.

Answered: 1 week ago

Question

Identify and use the five steps for conducting research.

Answered: 1 week ago

Question

List the goals of a persuasive message.

Answered: 1 week ago